This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992:12:59-79.

The p53 tumour suppressor gene and product

A J Levine¹

Affiliations

PMID: 1638548

Review

The p53 tumour suppressor gene and product

A J Levine. Cancer Surv. 1992.

. 1992:12:59-79.

Author

A J Levine¹

Affiliation

¹ Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, New Jersey 08544-1014.

PMID: 1638548

No abstract available

PubMed Disclaimer

Similar articles

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Greenblatt MS, et al. Cancer Res. 1994 Sep 15;54(18):4855-78. Cancer Res. 1994. PMID: 8069852 Review. No abstract available.
p53: balancing tumour suppression and implications for the clinic.
Buganim Y, Rotter V. Buganim Y, et al. Eur J Cancer. 2009 Sep;45 Suppl 1:217-34. doi: 10.1016/S0959-8049(09)70037-1. Eur J Cancer. 2009. PMID: 19775621
11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product.
Levine AJ. Levine AJ. Biol Chem Hoppe Seyler. 1993 Apr;374(4):227-35. Biol Chem Hoppe Seyler. 1993. PMID: 8329141 Review. No abstract available.
TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
Wang XW, Harris CC. Wang XW, et al. Cancer Surv. 1996;28:169-96. Cancer Surv. 1996. PMID: 8977035 Review.
p53: from clinical significance to significance in the clinic?
Hall AR, Braithwaite A. Hall AR, et al. N Z Med J. 1997 Sep 26;110(1052):347-8. N Z Med J. 1997. PMID: 9364174 Review. No abstract available.

See all similar articles

Cited by

Biological indices in the assessment of breast cancer.
Leong AS, Lee AK. Leong AS, et al. Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221. Clin Mol Pathol. 1995. PMID: 16696013 Free PMC article. No abstract available.
P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions.
Sul J, Yu GP, Lu QY, Lu ML, Setiawan VW, Wang MR, Guo CH, Yu SZ, Mu L, Cai L, Kurtz RC, Zhang ZF. Sul J, et al. Cancer Lett. 2006 Jul 18;238(2):210-23. doi: 10.1016/j.canlet.2005.07.004. Epub 2005 Aug 19. Cancer Lett. 2006. PMID: 16111803 Free PMC article.
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.
Friess H, Berberat P, Schilling M, Kunz J, Korc M, Büchler MW. Friess H, et al. J Mol Med (Berl). 1996 Jan;74(1):35-42. doi: 10.1007/BF00202070. J Mol Med (Berl). 1996. PMID: 8834768 Review.
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.
Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D. Levine AJ, et al. Br J Cancer. 1994 Mar;69(3):409-16. doi: 10.1038/bjc.1994.76. Br J Cancer. 1994. PMID: 8123467 Free PMC article. Review.
Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression.
Hirano T, Franzén B, Kato H, Ebihara Y, Auer G. Hirano T, et al. Am J Pathol. 1994 Feb;144(2):296-302. Am J Pathol. 1994. PMID: 7906095 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Molecular Biology Databases
- Mouse Genome Informatics (MGI)
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal